Diabetes is an Independent Growth Factor of Ischemic Stroke During Reperfusion Phase Leading to Poor Clinical Outcome.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 03 09 2021
revised: 16 03 2022
accepted: 24 03 2022
pubmed: 27 4 2022
medline: 25 5 2022
entrez: 26 4 2022
Statut: ppublish

Résumé

Despite the success of recanalization by bridging therapy, about half of treated stroke patients remain disabled. While numerous reports propose clinical predictors of stroke clinical outcome in this context, we originally aimed to study pre-therapeutic factors influencing infarct growth (IG) and poor clinical outcome in strokes due to large vessel occlusion (LVO) successfully recanalized. We enrolled 87 consecutive successfully recanalized patients (mTICI: 2b/2c/3) by mechanical thrombectomy (±rt-PA) after stroke due to middle cerebral artery (M1) occlusion within 6 h according to AHA guidelines. IG was defined by subtracting the initial DWI volume to the final 24 h-TDM volume. Statistical associations between poor clinical outcome (mRS≥2), IG and pertinent clinico-radiological variables, were measured using logistic and linear regression models. Among 87 enrolled patients (Age(y): 68.4 ± 17.5; NIHSS: 16.0 ± 5.4), 42/87 (48,28%) patients had a mRS ≥ 2 at 3 months. Diabetic history (OR: 3.70 CI95%[1.03;14.29] and initial NIHSS (/1 point: OR: 1.16 CI95%[1.05;1.27]) were independently associated with poor outcome. IG was significantly higher in stroke patients with poor outcome (+7.57 ± 4.52 vs -7.81 ± 1.67; p = 0.0024). Initial volumes were not significantly different (mRS≥2: 16.18 ± 2.67; mRS[0-1]: 14.70 ± 2.30; p = 0.6771). Explanatory variables of IG in linear regression were diabetic history (β: 21.26 CI95%[5.43; 37.09]) and NIHSS (β: 0.83 CI95%[0.02; 1.64]). IG was higher in diabetic stroke patients (23.54 ± 1.43 vs -6.20 ± 9.36; p = 0.0061). We conclude that diabetes leads to continued IG after complete recanalization, conditioning clinical outcome in LVO strokes successfully recanalized by bridging therapy. We suggest that poor tissular reperfusion by diabetic microangiopathy could explain this result.

Identifiants

pubmed: 35472652
pii: S1052-3057(22)00173-2
doi: 10.1016/j.jstrokecerebrovasdis.2022.106477
pii:
doi:

Substances chimiques

Intercellular Signaling Peptides and Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106477

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of compecting interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jean-Daniel Dehondt (JD)

Stroke Unit, University Hospital of Marseille (AP-HM), Marseille, France; Center for Cardiovascular and Nutrition Research (C2VN), Aix Marseille University, Marseille, France.

Quentin Holay (Q)

Radiology Unit, Teaching Military Hospital, Toulon.

Sacha Brohee (S)

Stroke Unit, University Hospital of Marseille (AP-HM), Marseille, France.

Hélène Mourre (H)

Stroke Unit, University Hospital of Marseille (AP-HM), Marseille, France.

Jean-François Hak (JF)

Neuroradiology Department, University Hospital of Marseille (AP-HM), Marseille, France.

Ophélie Osman (O)

Stroke Unit, University Hospital of Marseille (AP-HM), Marseille, France.

Laurent Suissa (L)

Stroke Unit, University Hospital of Marseille (AP-HM), Marseille, France; Center for Cardiovascular and Nutrition Research (C2VN), Aix Marseille University, Marseille, France.

Emilie Doche (E)

Stroke Unit, University Hospital of Marseille (AP-HM), Marseille, France; Center for Cardiovascular and Nutrition Research (C2VN), Aix Marseille University, Marseille, France. Electronic address: emilie.doche@ap-hm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH